Whether it will continue the policy of prescribing beta interferon through the NHS to those people diagnosed with multiple sclerosis who it…

I have asked the Health Technology Board for Scotland to provide NHSScotland with a Scottish Comment on the National Institute for Clinical Excellence (NICE) guidance on beta interferon and glatiramer when this is available. As with all medicines, the decision whether or not to prescribe beta interferon for an individual patient depends on the clinical judgement of the specialist concerned, in consultation with the patient. The specialist should take into account the risks and benefits of that treatment as indicated in advice provided by their local Area Drug and Therapeutic Committee.